Table 1 Patient clinical and pathological details. Gleason Score, Grade Group and PIRADS v2 (1) are reported for the dominant intraprostatic lesion. PSA = prostate specific antigen
Variable (n = 61) | Mean | Range |
|---|---|---|
Age | 62 | (45, 74) |
PSA (ng/mL) | 9.0 | (2.2, 42) |
n (%) | ||
Gleason Score / Grade Group | ||
- 3 + 3 / 1 | 4 (6.6) | |
- 3 + 4 / 2 | 31 (50.8) | |
- 4 + 3 / 3 | 20 (32.8) | |
- 4 + 5 / 5 | 3 (4.9) | |
- 5 + 4 / 5 | 3 (4.9) | |
Extraprostatic extension | 27 (44.3) | |
Pathological T Stage | ||
- pT2 | 30 (49.2) | |
- pT3a | 23 (37.7) | |
- pT3b | 8 (13.1) | |
PIRADs v2 | ||
- 1 | 1 (1.6) | |
- 2 | 7 (11.5) | |
- 3 | 10 (16.4) | |
- 4 | 10 (16.4) | |
- 5 | 31 (50.8) | |
- indeterminate | 2 (3.3) | |